Stay updated on Venetoclax/Azacitidine Maintenance in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.

Latest updates to the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer now shows 'Revision: v3.3.3' and the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe page history now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved the general government funding status notice from the page, a minor content change that does not affect study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check66 days agoChange DetectedNew version entries have been added to the Record History, updating the list with recent submission dates and changes to sections such as Study Status and Contacts/Locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check95 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference8%

- Check102 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

Stay in the know with updates to Venetoclax/Azacitidine Maintenance in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.